Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter Randomized Double-Blind Controlled Trial of Six-Week Transcranial Temporal Interference Stimulation（TIS） Targeting the Right Amygdala for Rapid Alleviation of Depressive Symptoms.

NCT07059143 is registered in ClinicalTrials.gov with Ruijin Hospital as lead sponsor.

NCT NCT07059143
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07059143 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter Randomized Double-Blind Controlled Trial of Six-Week Transcranial Temporal Interference Stimulation（TIS） Targeting the Right Amygdala for Rapid Alleviation of Depressive Symptoms.
Lead sponsor
Ruijin Hospital
Phase
Not applicable
Overall status
Completed
Start date
May 27, 2025
Completion date
July 8, 2026
Enrollment
38 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

major depressive disorder (mdd)